FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979262316> ?p ?o ?g. }

• W2979262316 endingPage "v709" @default.
• W2979262316 startingPage "v709" @default.
• W2979262316 abstract "Abstract Background Around half of patients with intermediate or high-grade soft tissue sarcomas (STS) will develop advanced disease. The mainstay of treatment for advanced STS is chemotherapy. Although treatment intent is usually palliative, the degree to which chemotherapy affects symptoms of disease, patient functioning and health-related quality of life (HRQoL) is rarely measured nor incorporated into clinical trials. Radiological response rates, time to progression and survival are traditionally used to measure treatment benefit. Therapeutic decisions are often challenging due to modest response rates and treatment-related adverse events. HRQoL is perceived by some patients as of equal- or greater importance than survival. Clinicians should be able to provide HRQoL data to patients to enhance the shared decision-making process and encourage a holistic approach to care. The aim of this study is to assess HRQoL in patients with advanced STS treated with 1st line chemotherapy, explore the decision-making process and evaluate patient post-treatment reflection. Trial design This is a longitudinal cohort study for patients aged ≥18 years with advanced STS (n = 132) who are treated with 1st line chemotherapy. Patients from 8 centres (United Kingdom 3, The Netherlands 5) are invited to complete questionnaires at baseline, each cycle of chemotherapy and three-monthly during follow-up. Data collection will be done within PROFILES, an established international registry for cancer patient reported outcomes. Questionnaires include patient demographics, decisional conflict scale, control preferences scale, quality-quantity questionnaire, treatment expectations, EORTC-QLQ-C30, FACT-G (2 items), work-ability index, financial toxicity and decisional regret scale. Clinical details, such as STS histology, will be collected from patient records and linked to questionnaire data. The primary endpoint is change in global HRQoL from baseline to Cycle 4 of chemotherapy. Exploratory endpoints include HRQoL functioning scales and symptoms. Recruitment started February 2018; 57 patients have completed (at least) the baseline questionnaire. (May 2019). Clinical trial identification NCT03621332. Legal entity responsible for the study Institute of Cancer Research, London, United Kingdom and Radboud UMC, Nijmegen, Netherlands. Funding Has not received any funding. Disclosure All authors have declared no conflicts of interest." @default.
• W2979262316 created "2019-10-10" @default.
• W2979262316 creator A5002946130 @default.
• W2979262316 creator A5019313023 @default.
• W2979262316 creator A5036169129 @default.
• W2979262316 creator A5037532883 @default.
• W2979262316 creator A5038603211 @default.
• W2979262316 creator A5040551223 @default.
• W2979262316 creator A5049231040 @default.
• W2979262316 creator A5051744290 @default.
• W2979262316 creator A5062636955 @default.
• W2979262316 creator A5072207944 @default.
• W2979262316 creator A5076740454 @default.
• W2979262316 date "2019-10-01" @default.
• W2979262316 modified "2023-09-27" @default.
• W2979262316 title "Health-related quality of life in patients with advanced soft tissue sarcomas treated with chemotherapy: The HOLISTIC study" @default.
• W2979262316 doi "https://doi.org/10.1093/annonc/mdz283.069" @default.
• W2979262316 hasPublicationYear "2019" @default.
• W2979262316 type Work @default.
• W2979262316 sameAs 2979262316 @default.
• W2979262316 citedByCount "0" @default.
• W2979262316 crossrefType "journal-article" @default.
• W2979262316 hasAuthorship W2979262316A5002946130 @default.
• W2979262316 hasAuthorship W2979262316A5019313023 @default.
• W2979262316 hasAuthorship W2979262316A5036169129 @default.
• W2979262316 hasAuthorship W2979262316A5037532883 @default.
• W2979262316 hasAuthorship W2979262316A5038603211 @default.
• W2979262316 hasAuthorship W2979262316A5040551223 @default.
• W2979262316 hasAuthorship W2979262316A5049231040 @default.
• W2979262316 hasAuthorship W2979262316A5051744290 @default.
• W2979262316 hasAuthorship W2979262316A5062636955 @default.
• W2979262316 hasAuthorship W2979262316A5072207944 @default.
• W2979262316 hasAuthorship W2979262316A5076740454 @default.
• W2979262316 hasBestOaLocation W29792623161 @default.
• W2979262316 hasConcept C126322002 @default.
• W2979262316 hasConcept C136948725 @default.
• W2979262316 hasConcept C141071460 @default.
• W2979262316 hasConcept C142724271 @default.
• W2979262316 hasConcept C143998085 @default.
• W2979262316 hasConcept C159110408 @default.
• W2979262316 hasConcept C2776694085 @default.
• W2979262316 hasConcept C2778256501 @default.
• W2979262316 hasConcept C2778336483 @default.
• W2979262316 hasConcept C2778629024 @default.
• W2979262316 hasConcept C2779951463 @default.
• W2979262316 hasConcept C71924100 @default.
• W2979262316 hasConceptScore W2979262316C126322002 @default.
• W2979262316 hasConceptScore W2979262316C136948725 @default.
• W2979262316 hasConceptScore W2979262316C141071460 @default.
• W2979262316 hasConceptScore W2979262316C142724271 @default.
• W2979262316 hasConceptScore W2979262316C143998085 @default.
• W2979262316 hasConceptScore W2979262316C159110408 @default.
• W2979262316 hasConceptScore W2979262316C2776694085 @default.
• W2979262316 hasConceptScore W2979262316C2778256501 @default.
• W2979262316 hasConceptScore W2979262316C2778336483 @default.
• W2979262316 hasConceptScore W2979262316C2778629024 @default.
• W2979262316 hasConceptScore W2979262316C2779951463 @default.
• W2979262316 hasConceptScore W2979262316C71924100 @default.
• W2979262316 hasLocation W29792623161 @default.
• W2979262316 hasOpenAccess W2979262316 @default.
• W2979262316 hasPrimaryLocation W29792623161 @default.
• W2979262316 hasRelatedWork W1966762476 @default.
• W2979262316 hasRelatedWork W1980046025 @default.
• W2979262316 hasRelatedWork W1993756708 @default.
• W2979262316 hasRelatedWork W2150538964 @default.
• W2979262316 hasRelatedWork W2159576994 @default.
• W2979262316 hasRelatedWork W2299815753 @default.
• W2979262316 hasRelatedWork W2383467646 @default.
• W2979262316 hasRelatedWork W2585010490 @default.
• W2979262316 hasRelatedWork W2904628587 @default.
• W2979262316 hasRelatedWork W2980400893 @default.
• W2979262316 hasVolume "30" @default.
• W2979262316 isParatext "false" @default.
• W2979262316 isRetracted "false" @default.
• W2979262316 magId "2979262316" @default.
• W2979262316 workType "article" @default.